Gene therapy • Clinical-stage
Atsena Therapeutics is a clinical-stage gene therapy company focused on developing treatments for inherited retinal diseases such as X-linked retinoschisis and Leber congenital amaurosis type 1.
Biopharma • Obesity Treatment
Helicore Biopharma develops glucose-dependent insulinotropic peptide (GIP) antagonist therapies for obesity treatment.
VTOL • Aircraft
Archer Aviation develops hybrid VTOL aircraft for defense applications, leveraging rapid aircraft development and AI systems integration.
Medical device • Neuromodulation
Saluda Medical develops and commercializes the Evoke® System, a closed-loop spinal cord stimulation device for managing chronic pain.
Biopharmaceutical • Ion Channel Modulators
SiteOne Therapeutics is a biopharmaceutical company developing selective, small molecule ion channel modulators for treating sensory hyperexcitability disorders like pain and chronic cough.
Epigenetic editing • Genetic medicines
nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.
AI-driven • Robotic systems
Amp Robotics provides AI-driven robotic systems for waste sorting on an "as a service" model, charging per ton of waste sorted.
Medical Technology • Diabetes Management
Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.
Simulation • Testing
Trace Machina develops a simulation testing platform called NativeLink to test and validate software for autonomous systems like self-driving cars and robotics.
AI-driven solutions • Social Security Disability benefits
Mindset Care simplifies Social Security Disability benefits applications for individuals with serious mental illnesses using AI-driven solutions and experienced disability attorneys.
Biopharmaceutical • Respiratory Diseases
Avalyn Pharma is a biopharmaceutical company that develops inhalation therapies for rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases, with a focus on creating new inhaled formulations of approved medicines.
Precision Oncology • Clinical Development
FORE Biotherapeutics is a precision oncology company that focuses on the clinical development of plixorafenib, a novel small-molecule inhibitor for treating BRAF-altered tumors.